Last Week Of Fun In The Markets? Click to watch.

Coherus BioSciences Stock Forecast

NASDAQ:CHRS BUY SELL

$7.24 (-2.16%)

Volume: 594.949k

Closed: Jun 30, 2022

Hollow Logo Score: 0.545

Coherus BioSciences Stock Forecast

BUY SELL NASDAQ:CHRS
$7.24 (-2.16%)

Volume: 594.949k

Closed: Jun 30, 2022

Score Hollow Logo 0.545

CHRS Price Targets and Analyst Ratings NASDAQ:CHRS

Historical Ratings and Targets

Date Upside / Downside Analyst Firm Price Target Change Rating Change Previous / Current Rating
2022-06-14 -3.31% UBS $7.00 Initiates Coverage On Neutral
2022-05-20 245.3% Mizuho $30.00 $25.00 Maintains Buy
2022-05-09 107.18% Barclays $20.00 $15.00 Maintains Overweight
2022-03-07 107.18% JP Morgan $15.00 Downgrades Overweight Neutral
2021-11-09 314.36% HC Wainwright & Co. $36.00 $30.00 Maintains Buy
2021-07-23 397.24% HC Wainwright & Co. $26.00 $36.00 Maintains Buy
2021-05-17 231.49% Barclays $28.00 $24.00 Maintains Overweight
2021-05-07 259.12% HC Wainwright & Co. $29.00 $26.00 Maintains Buy
2021-02-25 300.55% HC Wainwright & Co. $33.00 $29.00 Maintains Buy
2020-11-19 314.36% Mizuho $35.00 $30.00 Maintains Buy
2020-11-06 341.99% HC Wainwright & Co. $33.00 $32.00 Maintains Buy
2020-08-10 314.36% Truist Securities $26.00 $30.00 Maintains Buy
2020-08-07 355.8% HC Wainwright & Co. $30.00 $33.00 Maintains Buy
2020-07-16 176.24% B of A Securities $20.00 Initiates Coverage On Neutral
2020-04-17 259.12% SunTrust Robinson Humphrey $26.00 Initiates Coverage On Buy
2020-02-28 314.36% HC Wainwright & Co. $29.00 $30.00 Reiterates Buy
2020-02-06 383.43% JP Morgan $33.00 $35.00 Maintains Overweight
2019-11-07 328.18% Citigroup $27.00 $31.00 Maintains Buy
2019-08-13 493.92% Mizuho $43.00 Initiates Coverage On Buy
2019-06-11 314.36% Barclays $30.00 Initiates Coverage On Overweight

CHRS Stock Trend

The stock lies the upper part of a very wide and falling trend in the short term, and this may normally pose a very good selling opportunity for the short-term trader as reaction back towards the lower part of the trend can be expected. A break up at the top trend line at $7.33 will firstly indicate a slower falling rate, but may be the first sign of a trend shift.

Given the current short-term trend, the stock is expected to fall -45.58% during the next 3 months and, with a 90% probability hold a price between $2.70 and $3.99 at the end of this 3-month period. Do note, that if the stock price manages to stay at current levels or higher, our prediction target will start to change positively over the next few days as the conditions for the current predictions will be broken.

Data

Date Bottom Mid Top
2022-07-05 $4.87 $6.05 $7.23
2022-07-06 $4.77 $5.95 $7.13
2022-07-07 $4.67 $5.85 $7.04
2022-07-08 $4.57 $5.75 $6.94
2022-07-11 $4.47 $5.66 $6.84
2022-07-12 $4.37 $5.56 $6.74
2022-07-13 $4.28 $5.46 $6.64
2022-07-14 $4.18 $5.36 $6.54
2022-07-15 $4.08 $5.26 $6.44
2022-07-18 $3.98 $5.16 $6.34
2022-07-19 $3.88 $5.06 $6.24
2022-07-20 $3.78 $4.96 $6.14
2022-07-21 $3.68 $4.86 $6.05
2022-07-22 $3.58 $4.76 $5.95
2022-07-25 $3.48 $4.67 $5.85
2022-07-26 $3.38 $4.57 $5.75
2022-07-27 $3.28 $4.47 $5.65
2022-07-28 $3.19 $4.37 $5.55
2022-07-29 $3.09 $4.27 $5.45
2022-08-01 $2.99 $4.17 $5.35
2022-08-02 $2.89 $4.07 $5.25
2022-08-03 $2.79 $3.97 $5.15
2022-08-04 $2.69 $3.87 $5.05
2022-08-05 $2.59 $3.77 $4.96
2022-08-08 $2.49 $3.67 $4.86
2022-08-09 $2.39 $3.58 $4.76
2022-08-10 $2.29 $3.48 $4.66
2022-08-11 $2.20 $3.38 $4.56
2022-08-12 $2.10 $3.28 $4.46
2022-08-15 $2.00 $3.18 $4.36

IMPROVE YOUR TRADING GAME WITH A GOLDEN STAR

From 27 537 stocks, only a few dozen will trigger such a signal!

About Coherus BioSciences

Coherus BioSciences Coherus Biosciences, Inc., a late-stage clinical biologics platform company, focuses on developing and commercializing biosimilar products worldwide. The company’s product candidates include CHS-1701, a pegfilgrastim biosimilar candidate, which has completed a Phase I study for the prevention of chemotherapy-induced neutropenia; CHS-0214, an etanercept biosimilar candidate, which is in Phase III clinical trials for the treatment of rheumatoid ar... Read more

.

StockInvest.usStock Podcast

Top Fintech Company

StockInvest.us featured in The Global Fintech Index 2020 as the top Fintech company of the country.

Full report by FINDEXABLE

ROCKIT